EXACT Sciences Corp. (EXAS) to Release Quarterly Earnings on Tuesday
EXACT Sciences Corp. (NASDAQ:EXAS) is scheduled to be announcing its Q313 earnings results on Tuesday, October 29th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $1.02 million for the quarter.
EXACT Sciences Corp. (NASDAQ:EXAS) opened at 11.09 on Monday. EXACT Sciences Corp. has a 52-week low of $6.93 and a 52-week high of $14.70. The stock’s 50-day moving average is $12.54 and its 200-day moving average is $11.57. The company’s market cap is $784.0 million.
A number of research firms have recently commented on EXAS. Analysts at Wedbush upgraded shares of EXACT Sciences Corp. from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday, October 16th. On a related note, analysts at Summer Street initiated coverage on shares of EXACT Sciences Corp. in a research note to investors on Monday, September 16th. They set a “buy” rating on the stock. Finally, analysts at Benchmark Co. initiated coverage on shares of EXACT Sciences Corp. in a research note to investors on Tuesday, September 10th. They set a “speculative buy” rating and a $20.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $15.78.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.